和铂医药-B(02142)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02142 和铂医药-B

午间休市 02-05 12:05:00

11.130

-0.030

-0.27%

最高11.490	最低11.050	成交量147.00万
今开11.290	昨收11.160	日振幅3.94%
总市值96.61亿	流通市值96.61亿	总股本8.68亿
成交额1,648万	换手率0.17%	流通股本8.68亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02142","market":"HK","secType":"STK","nameCN":"和铂医药-B","latestPrice":11.13,"timestamp":1770264300004,"preClose":11.16,"halted":0,"volume":1470000,"delay":0,"changeRate":-0.0026881720430106952,"floatShares":868000000,"shares":868000000,"eps":0.003616,"marketStatus":"午间休市","change":-0.03,"latestTime":"02-05 12:05:00","open":11.29,"high":11.49,"low":11.05,"amount":16482245,"amplitude":0.039427,"askPrice":11.21,"askSize":31000,"bidPrice":11.13,"bidSize":8000,"shortable":3,"etf":0,"ttmEps":0.661,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770267600000},"marketStatusCode":3,"adr":0,"listingDate":1607529600000,"exchange":"SEHK","adjPreClose":11.16,"openAndCloseTimeList":[[1770255000000,1770264000000],[1770267600000,1770278400000]],"volumeRatio":0.954076,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02142","defaultTab":"news","newsList":[{"id":"2608877003","title":"港股异动 | 和铂医药-B(02142)盈喜后高开逾3% 预期年度溢利至多约9500万美元 公司经常性收入持续增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2608877003","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608877003?lang=zh_cn&edition=full","pubTime":"2026-02-04 09:23","pubTimestamp":1770168199,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，和铂医药-B盈喜后高开逾3%，截至发稿，涨3.44%，报11.44港元，成交额48.05万港元。消息面上，2月4日，和铂医药-B发布公告，预期截至2025年12月31日止年度的溢利介乎约8800万美元至约9500万美元，而截至2024年12月31日止年度则为溢利约270万美元。预期经调整溢利总额介乎9100万美元至9800万美元。公告称，公司预期溢利增加主要归因于：公司的经常性收入的持续增长，例如与阿斯利康及百时美施贵宝开展基于平台的研究合作。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1401363.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02142","VXUS","BK1574","BK1161","BK1583","BK4588","BK4585","VT"],"gpt_icon":0},{"id":"2608384676","title":"和铂医药-B(02142.HK)：预期2025年经调整溢利总额9100万至9800万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608384676","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608384676?lang=zh_cn&edition=full","pubTime":"2026-02-04 08:17","pubTimestamp":1770164221,"startTime":"0","endTime":"0","summary":"格隆汇2月4日丨和铂医药-B发布公告，预期截至2025年12月31日止年度的溢利介乎约8800万美元至约9500万美元，而截至2024年12月31日止年度则为溢利约270万美元。预期经调整溢利总额介乎9100万美元至9800万美元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260204/31996719.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1161","BK1583","BK1574","02142"],"gpt_icon":0},{"id":"2608826456","title":"每日卖空追踪 | 和铂医药-B 02月03日卖空量成交20.4万股，卖空比例为7.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608826456","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608826456?lang=zh_cn&edition=full","pubTime":"2026-02-03 16:30","pubTimestamp":1770107427,"startTime":"0","endTime":"0","summary":"和铂医药-B北京时间02月03日，跌2.12%，卖空量成交20.4万股，较上一交易日减少77.53%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203163438a6cdb7a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203163438a6cdb7a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1574","02142","BK1161"],"gpt_icon":0},{"id":"2608835776","title":"和铂医药-B盘中异动 早盘股价大跌5.04%报11.300港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608835776","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608835776?lang=zh_cn&edition=full","pubTime":"2026-02-02 10:17","pubTimestamp":1769998678,"startTime":"0","endTime":"0","summary":"2026年02月02日早盘10时17分，和铂医药-B股票出现异动，股价快速跳水5.04%。截至发稿，该股报11.300港元/股，成交量62.3万股，换手率0.07%，振幅4.20%。资金方面，该股资金流入291.02万港元，流出373.703万港元。和铂医药-B股票所在的生物技术行业中，整体跌幅为2.80%。其相关个股中，中生北控生物科技、思路迪医药股份、嘉和生物涨幅较大，振幅较大的相关个股有中慧生物-B、瑞博生物-B、康方生物，振幅分别为13.59%、10.25%、9.06%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202101758a4713e6a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202101758a4713e6a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","02142","BK1583"],"gpt_icon":0},{"id":"2607084115","title":"每日卖空追踪 | 和铂医药-B 01月29日卖空量成交75.5万股，卖空比例为19.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607084115","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607084115?lang=zh_cn&edition=full","pubTime":"2026-01-29 16:30","pubTimestamp":1769675429,"startTime":"0","endTime":"0","summary":"和铂医药-B北京时间01月29日，涨0.76%，卖空量成交75.5万股，较上一交易日减少34.91%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129163948a463ea53&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129163948a463ea53&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1583","BK1574","02142"],"gpt_icon":0},{"id":"2607246927","title":"和铂医药-B(02142)拟回购不超过3亿港元的公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2607246927","media":"智通财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607246927?lang=zh_cn&edition=full","pubTime":"2026-01-29 08:06","pubTimestamp":1769645177,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和铂医药-B(02142)发布公告，根据公司股东于公司2025年6月11日举行的股东周年大会上批准的购回股份的一般授权及(如适用)未来股东于公司不时的股东大会上批准的购回股份的任何一般授权，其拟不时于公开市场上购回价值不超过3亿港元的公司股份。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1398872.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"和铂医药-B(02142)拟回购不超过3亿港元的公司股份","news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02142","BK1161","BK1583","BK1574"],"gpt_icon":0},{"id":"2606768622","title":"和铂医药全人源抗体技术平台：助力开发高危禽流感H5N1中和抗体","url":"https://stock-news.laohu8.com/highlight/detail?id=2606768622","media":"医药笔记","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606768622?lang=zh_cn&edition=full","pubTime":"2026-01-28 08:20","pubTimestamp":1769559644,"startTime":"0","endTime":"0","summary":"在这种背景下，高效中和抗体的研发有望为防控H5N1提供重要工具。和铂医药为全人源抗体转基因小鼠技术的领军企业之一，上述文章利用的H2L2 Harbour Mice为其核心技术平台之一，具有与正常小鼠相当的免疫反应，包含多元人V基因，可以产生具有κ轻链和IgG1、IgG2b、IgG2c即IgM重链的抗体。此外，和铂医药还有HCAbHarbour Mice仅重链抗体转基因小鼠技术平台。此次合作方西奈山医学院高效地筛选出H5N1中和抗体，进一步证明了其抗体发现技术平台的价值。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128093218a45e0c60&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128093218a45e0c60&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02142","BK1583","BK1574","BK1161"],"gpt_icon":0},{"id":"2606730247","title":"每日卖空追踪 | 和铂医药-B 01月27日卖空量成交18万股，卖空比例为3.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606730247","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606730247?lang=zh_cn&edition=full","pubTime":"2026-01-27 16:30","pubTimestamp":1769502630,"startTime":"0","endTime":"0","summary":"和铂医药-B北京时间01月27日，跌4.03%，卖空量成交18万股，较上一交易日减少81.27%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127164024a6b236e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127164024a6b236e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02142","BK1583","BK1574","BK1161"],"gpt_icon":0},{"id":"2606473022","title":"和铂医药-B01月27日主力净流出673.4万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2606473022","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606473022?lang=zh_cn&edition=full","pubTime":"2026-01-27 16:15","pubTimestamp":1769501733,"startTime":"0","endTime":"0","summary":"01月27日, 和铂医药-B股价跌4.03%，报收11.42元，成交金额6639.3万元，换手率0.66%，振幅5.88%，量比1.40。和铂医药-B今日主力资金净流出673.4万元，上一交易日主力净流入51.7万元。该股近5个交易日下跌11.21%，主力资金累计净流出20.9万元；近20日主力资金累计净流入3372.7万元，其中净流入天数为15日。该股主力净额占比0.07%，港股市场排名2602/2708。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127161825a6b21eea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127161825a6b21eea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02142","BK1161","BK1583","BK1574"],"gpt_icon":0},{"id":"2606206727","title":"2025年中国创新药对外授权交易额超1300亿美元创纪录","url":"https://stock-news.laohu8.com/highlight/detail?id=2606206727","media":"DoNews","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606206727?lang=zh_cn&edition=full","pubTime":"2026-01-27 15:31","pubTimestamp":1769499062,"startTime":"0","endTime":"0","summary":"2025年，中国创新药对外授权交易总金额超过1300亿美元，交易数量逾150笔，占全球总量约40%，创下历史新高。阿斯利康在2025年3月初宣布25亿美元投资计划，涵盖三项BD交易及一笔收购。辉瑞与三生制药于2025年5月达成的交易刷新中国创新药出海首付款纪录，达12.5亿美元；礼来全部4笔交易均为技术平台合作，其中2笔涉及晶泰控股与英硅智能。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127153959a6b1f6d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127153959a6b1f6d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06978","BK1574","01276","01801","01093","01530","03696","BK1161","02509","02142","03692"],"gpt_icon":0},{"id":"2606326296","title":"【券商聚焦】招银国际：创新药出海趋势长期将延续","url":"https://stock-news.laohu8.com/highlight/detail?id=2606326296","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606326296?lang=zh_cn&edition=full","pubTime":"2026-01-26 13:17","pubTimestamp":1769404672,"startTime":"0","endTime":"0","summary":"金吾财讯 | 招银国际表示，MSCI中国医疗指数2026年初至今累计上涨9.2%，跑赢MSCI中国指数5.6%。展望2026年，创新药出海趋势长期将延续，该机构将重点关注已出海管线的临床进展与数据兑现的核心催化。年初多个创新药BD交易落地，中国创新药出海的趋势向好。该机构认为，中国企业对于临床前分子的转让或将谨慎，未来中国出海分子将大多在具备中国早期临床试验数据的基础上达成，以获得更高的交易价值。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250109/ODYzMTA4NTI1Nzg5MjIw.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/ODYzMTA4NTI1Nzg5MjIw.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1973928","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0588546209.SGD","LU1794554557.SGD","LU1242518931.SGD","LU1880383366.USD","06185","SG9999002463.SGD","LU1303224171.USD","09995","SG9999002562.SGD","02142","IE00B5MMRT66.SGD","LU0348825331.USD","159992","LU0043850808.USD","LU3063872942.SGD","LU2399975544.HKD","LU1960683339.HKD","BK1576","09688","LU0348784397.USD","01877","BK1500","06160","02269","LU0456827905.SGD","LU0417516902.SGD","LU0516423091.SGD","LU1226287529.USD","01177","LU0359201612.USD","LU0979878070.USD","LU1969619763.USD","IE00BZ08YS42.EUR","02616","LU2242644610.SGD","LU0051755006.USD","BK1588","LU0348767384.USD","LU1807302812.USD","LU0708995583.HKD","01093","IE00BZ08YT58.USD","LU0315179316.USD","01801","LU0516422440.USD","06978","LU0516422952.EUR","LU1226287875.USD","IE00B031HY20.USD","09926"],"gpt_icon":0},{"id":"2605288512","title":"和铂医药11亿美元授权合作生变","url":"https://stock-news.laohu8.com/highlight/detail?id=2605288512","media":"中国经营网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605288512?lang=zh_cn&edition=full","pubTime":"2026-01-24 04:25","pubTimestamp":1769199910,"startTime":"0","endTime":"0","summary":"一场耗时数年的国际药物研发合作戛然而止。近日，《中国经营报》记者在ClinicalTrials官网查询信息发现，辉瑞在该平台更新了其靶向间皮素的ADC药物PF-08052666（又称HBM9033或SGN-MesoC2）的状态：从“招募中”变为“不招募”。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601243629452483.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","BK1583","BK1574","02142"],"gpt_icon":0},{"id":"2605644719","title":"每日卖空追踪 | 和铂医药-B 01月22日卖空量成交60.3万股，卖空比例为9.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605644719","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605644719?lang=zh_cn&edition=full","pubTime":"2026-01-22 16:30","pubTimestamp":1769070628,"startTime":"0","endTime":"0","summary":"和铂医药-B北京时间01月22日，跌4.07%，卖空量成交60.3万股，较上一交易日减少30.85%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260122163603a69fc950&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260122163603a69fc950&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02142","BK1583","BK1574"],"gpt_icon":0},{"id":"2604989131","title":"每日卖空追踪 | 和铂医药-B 01月19日卖空量成交16.3万股，卖空比例为4.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2604989131","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604989131?lang=zh_cn&edition=full","pubTime":"2026-01-19 16:30","pubTimestamp":1768811427,"startTime":"0","endTime":"0","summary":"和铂医药-B北京时间01月19日，跌5.63%，卖空量成交16.3万股，较上一交易日增加61.39%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260119164102a72bac16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260119164102a72bac16&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","02142","BK1583"],"gpt_icon":0},{"id":"2604319871","title":"和铂医药-B盘中异动 大幅下挫5.01%报13.660港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2604319871","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604319871?lang=zh_cn&edition=full","pubTime":"2026-01-19 10:09","pubTimestamp":1768788571,"startTime":"0","endTime":"0","summary":"2026年01月19日早盘10时09分，和铂医药-B股票出现波动，股价急速下跌5.01%。截至发稿，该股报13.660港元/股，成交量59.7万股，换手率0.07%，振幅4.45%。资金方面，该股资金流入180.636万港元，流出542.116万港元。和铂医药-B股票所在的生物技术行业中，整体跌幅为2.70%。其相关个股中，科笛-B、晶泰控股、中生北控生物科技涨幅较大，振幅较大的相关个股有中慧生物-B、基石药业-B、科笛-B，振幅分别为11.99%、8.67%、8.16%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260119100931a43ad264&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260119100931a43ad264&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02142","BK1574","BK1583"],"gpt_icon":0},{"id":"2604908326","title":"和铂医药-B(02142)：根据与Spruce订立的授权及合作协议行使认股权证","url":"https://stock-news.laohu8.com/highlight/detail?id=2604908326","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604908326?lang=zh_cn&edition=full","pubTime":"2026-01-19 08:11","pubTimestamp":1768781472,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和铂医药-B 发布公告，内容有关本公司孵化的创新型生物技术公司HBM Alpha Therapeutics与Spruce Biosciences Inc.订立授权及合作协议(该协议)，以推进针对多种疾病的新型促肾上腺皮质激素释放激素靶向疗法。根据该协议，HBMAT及其联属人士获得少数股权相关的认股权证以购买Spruce普通股股份。于2026年1月19日，本公司及HBMAT根据该协议行使认股权证。于行使认股权证后，本公司持有Spruce发行在外股份总数的约3.8%及Spruce全面摊薄股份的约3.1%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1394254.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1574","02142","BK1161"],"gpt_icon":0},{"id":"2604195920","title":"和铂医药获GIC Private Limited增持50万股 每股作价14.5128港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2604195920","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604195920?lang=zh_cn&edition=full","pubTime":"2026-01-18 16:47","pubTimestamp":1768726020,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　香港联交所最新资料显示，1月14日，GIC Private Limited增持和铂医药（02142）50万股，每股作价14.5128港元，总金额为725.64万港元。增持后最新持股数目为7195.4万股，最新持股比例为8.05%。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-01-18/doc-inhhthyv2088419.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02142","BK1161","BK1583","GIC","BK1574","BK4104"],"gpt_icon":0},{"id":"2603995866","title":"GIC Private Limited增持和铂医药(02142)50万股 每股作价14.5128港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603995866","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603995866?lang=zh_cn&edition=full","pubTime":"2026-01-16 20:29","pubTimestamp":1768566547,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，1月14日，GIC Private Limited增持和铂医药(02142)50万股，每股作价14.5128港元，总金额为725.64万港元。增持后最新持股数目为7195.4万股，最新持股比例为8.05%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1394039.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["GIC","BK4104","BK1574","BK1583","BK1161","02142"],"gpt_icon":0},{"id":"2603262688","title":"【券商聚焦】华泰证券：超预期创新药BD带动板块共振","url":"https://stock-news.laohu8.com/highlight/detail?id=2603262688","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603262688?lang=zh_cn&edition=full","pubTime":"2026-01-15 08:57","pubTimestamp":1768438620,"startTime":"0","endTime":"0","summary":"金吾财讯 | 华泰证券表示，步入2026年以来，港股创新药交易不足两周，但已如该机构预期迎来开门红。港股创新药板块流动性大幅修复，且随着JPM医药峰会本周拉开序幕，中国BD交易持续超预期，相比去年同期有较大增长。该机构认为开年以来的流动性修复将带来一波明确的创新药β行情，该机构看好突破前高。外需型CXO在新分子需求的驱动下，业绩持续超预期，有望和创新药实现共振。该机构建议策略上优选中美估值差距较大的创新药资产相应公司；受益于新分子药物（多肽、寡核苷酸及ADC）的涌现，外需型CXO龙头凭借充沛的在手订单+强劲的漏斗效应，整体业绩已进入加速上升通道。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250109/M2QyMTYxN2UxNmI4NDk2OTg5NThlNDVhNTUzNjZhZTcxMjcxMzE0NDc4MDA=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/M2QyMTYxN2UxNmI4NDk2OTg5NThlNDVhNTUzNjZhZTcxMjcxMzE0NDc4MDA=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1973256","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06978","LU1226288170.HKD","LU1960683339.HKD","02142","601688","LU0140636845.USD","06185","LU1719994722.HKD","06160","LU2476274308.USD","LU0561508036.HKD","LU1303224171.USD","01177","BK1574","BK1588","LU2097828714.EUR","LU0516422952.EUR","LU0819121731.USD","LU2328871848.SGD","IE00BPRC5H50.USD","LU0348825331.USD","159992","LU0823426480.USD","LU1934453819.USD","02616","LU0348783233.USD","BK1610","09926","IE00BZ08YR35.GBP","01877","01801","02269","LU1688375341.USD","LU1064131003.USD","LU1961090484.USD","BK1161","LU2488822045.USD","LU0856984785.SGD","LU1979443071.USD","SG9999004220.SGD","09688","LU0348827113.USD","LU1251922891.USD","LU1993786604.SGD","BK0028","09995","SG9999002463.SGD","01093","LU0072913022.USD","BK1515"],"gpt_icon":0},{"id":"2603632732","title":"每日卖空追踪 | 和铂医药-B 01月13日卖空量成交22.3万股，卖空比例为3.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603632732","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603632732?lang=zh_cn&edition=full","pubTime":"2026-01-13 16:30","pubTimestamp":1768293027,"startTime":"0","endTime":"0","summary":"和铂医药-B北京时间01月13日，涨4.23%，卖空量成交22.3万股，较上一交易日减少60.88%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113165241a71505f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113165241a71505f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02142","BK1161","BK1583","BK1574"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.063},{"period":"1month","weight":-0.1043},{"period":"3month","weight":-0.1402},{"period":"6month","weight":0.0731},{"period":"1year","weight":1.8689},{"period":"ytd","weight":-0.0822}],"compareEarnings":[{"period":"1week","weight":-0.0352},{"period":"1month","weight":0.019},{"period":"3month","weight":0.0136},{"period":"6month","weight":0.08},{"period":"1year","weight":0.2914},{"period":"ytd","weight":0.0475}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"和铂医药控股有限公司是一家主要从事肿瘤免疫学及免疫性疾病领域的创新疗法开发业务的投资控股公司。该公司的产品主要包括巴托利单抗（HBM9161）、HBM9378、HBM7020、TCE Program、普鲁苏拜单抗（HBM4003）以及HBM7022等。该公司产品主要用于治疗全身型重症肌无力（gMG）、慢性阻塞性肺病（COPD）、哮喘、自身免疫疾病、黑色素瘤、结直肠癌以及实体瘤等。该公司通过专有抗体技术平台“Harbour Mice”、“HBICE”、“HBICA”及单克隆B细胞筛选平台提供下一代抗体以及生物解决方案。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":0.083377},{"month":2,"riseRate":0.166667,"avgChangeRate":-0.01384},{"month":3,"riseRate":0.4,"avgChangeRate":0.046232},{"month":4,"riseRate":0.4,"avgChangeRate":0.013317},{"month":5,"riseRate":0.6,"avgChangeRate":0.040454},{"month":6,"riseRate":0.2,"avgChangeRate":-0.066065},{"month":7,"riseRate":0.4,"avgChangeRate":0.030357},{"month":8,"riseRate":0.2,"avgChangeRate":0.005624},{"month":9,"riseRate":0.4,"avgChangeRate":-0.065735},{"month":10,"riseRate":0,"avgChangeRate":-0.180686},{"month":11,"riseRate":0.8,"avgChangeRate":0.25789},{"month":12,"riseRate":0.6,"avgChangeRate":0.266929}],"exchange":"SEHK","name":"和铂医药-B","nameEN":"HBM HOLDINGS-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"和铂医药-B(02142)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供和铂医药-B(02142)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"和铂医药-B,02142,和铂医药-B股票,和铂医药-B股票老虎,和铂医药-B股票老虎国际,和铂医药-B行情,和铂医药-B股票行情,和铂医药-B股价,和铂医药-B股市,和铂医药-B股票价格,和铂医药-B股票交易,和铂医药-B股票购买,和铂医药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"和铂医药-B(02142)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供和铂医药-B(02142)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}